What We're Reading: COVID-19 Testing Lags; Malaria Drugs Get Emergency Approval; Shutdown Extended
The reasons behind coronavirus disease 2019 (COVID-19) testing lags; FDA issues emergency authorization of malaria drugs for treatment of COVID-19; an expert from the University of Washington predicts that there could be at least 1 more extension of social distancing, beyond President Trump's announcement extending coronavirus guidelines to April 30.
Reasons Behind COVID-19 Testing Result Lags
In a piece published by
FDA Issues Emergency Authorization of Antimalarial Drugs
As Guidelines for Distancing Extend, One Projection Hints at Even Longer Time Frame
Despite scant evidence of its efficacy against COVID-19, the FDA issued an emergency use authorization for hydroxychloroquine and chloroquine, decades-old malaria drugs touted by President Trump.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025